FewerJobs.
All jobs

Manager, Cost Accounting

Cogent Biosciences Inc - Waltham, Massachusetts, United States

Posted Oct 5, 2026

Benefits

Parental leave
Not verified
Non-birth-parent leave
Not verified
Family-building benefits
  • Fertility benefits: Not verified
  • Adoption assistance: Not verified
  • Surrogacy assistance: Not verified
Mental health support
Not verified
Relocation assistance
Not verified
Childcare support
Not verified
Learning budget
Offered From the posting source checked Nov 16, 2026
Verification
Not verified checked Nov 20, 2026
Salary
$135K-$155K From the posting source checked Nov 16, 2026
401(k) match
Reported from DOL Form 5500 industry filing (not employer-specific)

Was this benefit information wrong? Tell us.

Market context

U.S. role benchmark (BLS OEWS)
$106,409 U.S. median for this role
Projected growth (BLS Employment Projections)
+7.7% - Faster than average

36% above the BLS role benchmark for finance aggregate.

Matched to SOC 13-2011 - Finance aggregate by role bucket.

Source:U.S. Bureau of Labor Statistics, OEWS, May 2024andEmployment Projections, 2024-2034.

Role

Role function
Finance From the posting source checked Nov 16, 2026
Seniority
Mid From the posting source checked Nov 16, 2026

Schedule

Shift type
Not verified
Weekend work
Not verified

Company

Equity
Offered Verified - SEC 10-K source checked Nov 16, 2026

Application

Cover letter
Not verified
Assessment
Not verified
Deadline
Not stated

Where they hire

State eligibility is not yet verified.

About this role

Manager, Cost Accounting Waltham, Massachusetts, United States Who We Are: Cogent Biosciences is a publicly traded biotechnology company focused on developing novel precision therapies to treat a broad range of patients with unmet medical needs. Cogent's lead program, bezuclastinib, is designed to selectively and potently inhibit exon 17 mutations found within the KIT receptor tyrosine kinase, including KIT D816V. KIT D816V is responsible for driving a rare and serious condition called Systemic Mastocytosis, and exon 17 mutations are also found in patients with gastrointestinal stromal tumors (GIST), a type of cancer with strong dependence on oncogenic KIT signaling. Bezuclastinib has exhibited promising initial data across all three trials: APEX in AdvSM, SUMMIT in NonAdvSM and PEAK in GIST, including an encouraging safety profile across 600+ patients in single agent and combination dosing. The Role: Cogent Biosciences is preparing for its first commercial launch and we are seeking a Manager, Cost Accounting to build and maintain the inventory and cost of goods sold processes. This role is responsible for ensuring accurate product costing, inventory valuation, variance analysis, and financial reporting in compliance with U.S. GAAP. This is a hands-on builder role suited for an experienced accountant with an expertise in pharmaceutical industry accounting practices, standard costing methodologies, inventory controls, and designing scalable accounting processes. This position reports to the Commercial Accounting Leader and will partner closely with Supply Chain, FP&A, Quality, Technical Operations, external vendors, and senior finance leadership to support the Company's transition to a commercial-stage organization. Responsibilities: - Maintain

Read the full description at job-boards.greenhouse.io. FewerJobs shows a preview and links to the original posting.

Apply at job-boards.greenhouse.io

Apply link verified; last checked Nov 20, 2026.

What verified means

Verified means a displayed claim has field-level provenance to a source FewerJobs pulled: a government or employer source, or the original job posting. Posting-sourced facts are employer-stated and are labeled separately from government records.

Related jobs